RET and cancer: Moreover, 31 inhibited cell proliferation with a similar potency for BaF3/CCDC6-RET cells and gatekeeper mutant V804 M-driven cell proliferation (IC50 value around 400 nM) highlighting that it could be active against both these RET-driven cancer cells.